8 September 2018 in International Journal of Applied Pharmaceutics
Objective: The objective of the present study was to formulate niosomal formulations of benazepril hydrochloride in an attempt to overcome the hurdles associated with itʼs poor oral absorption.Methods: Nine formulations were prepared with various ratios of sorbitan monostearate (span 60), sorbitan monopalmitate (span 40) and polyoxyethylene 2 stearyl ether (brij 72) as non-ionic surfactants, cholesterol as a stabilizing agent and soya lecithin as a charge imparting agent. Then, they were characterized for vesicle size, polydispersity (PDI), entrapment efficiency (EE %), release profile, zeta (ζ) potential and transmission electron microscopy (TEM).Results: Niosomal formulations exhibited an efficient entrapment range between (80.4-97.8) percent, vesicles size analyses revealed the formation of homogenously dispersed vesicles having a size range of (3.9±1.7-8.72±4.4) micrometers. The in vitro release studies revealed that all formulations displayed sustained release in comparison with the pure drug. Formulations prepared with span 60 and span 40 possessed adequate stability according to zeta potential analysis, whereas brij 72 failed the test and possessed inadequate zeta potential range. TEM images of the optimized formulations (F7 and F8) have confirmed the formation of vesicles with spherical shapes.Conclusion: Based on the study results, niosomal formulations seem to be attractive alternatives to conventional delivery for benazepril hydrochloride.
1 April 2017 in Asian Journal of Pharmaceutical and Clinical Research
Objective: The aim of this study was to formulate a new developed solid dispersion containing fixed dose combination of nalidixic acid and cefdinir (500:300 mg) to improve dissolution rate of poorly soluble drugs via a new mechanism as well as the conventional mechanism of solid dispersion represented by the presence of hydrophilic carrier.Methods:Through this objective eight newly developed solid dispersion formulas of fixed dose combination of nalidixic acid and cefdinir (500:300 mg) and (polyethylene glycol (PEG) 6000 and poloxamer 188) in different ratio were prepared, in addition to solid dispersion of each drug alone and simple mixture of individual solid dispersion prepared by means of fusion technique. Moreover, solid dispersions beside pure drugs, simple mixture and physical mixture were characterized by dissolution tests, solubility studies, powder x-ray diffractometry (PXRD), differential scanning calorimetry (DSC), FT-IR spectroscopy (FT-IR) and scanning electron microscopy (SEM).Results: From in vitro dissolution tests, PXRD, DSC, FT-IR, and SEM; it is indicated the presence of a physical complex between cefdinir and nalidixic acid in their solid dispersion containing combination of fixed dose of both drugs. This will affect the crystallinity of the second drug and their dissolution behavior in addition to the conventional mechanism owing to the presence of hydrophilic carrier (poloxamer 188).Conclusion: I was concluded that the newly prepared formula of solid dispersion containing fixed dose combination of nalidixic acid and cefdinir will be promising for higher dissolution profile than that from solid dispersion of each drug alone or simple mixture of individual solid dispersion of each drug.Keywords: Nalidixic acid, Cefdinir, Poloxamer 188, Polyethylene glycol 6000, Combinational solid dispersion, Fusion method.